search
Back to results

Alterations in Serotonergic Functions in Cocaine Addicts - 1

Primary Purpose

Cocaine-Related Disorders

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
M-CPP
Sponsored by
National Institute on Drug Abuse (NIDA)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cocaine-Related Disorders

Eligibility Criteria

25 Years - 50 Years (Adult)MaleDoes not accept healthy volunteers

Please contact site for information.

Sites / Locations

  • VA Medical Center

Outcomes

Primary Outcome Measures

Side effects
Neuroendocrine changes
Psychological changes
Craving

Secondary Outcome Measures

Full Information

First Posted
September 20, 1999
Last Updated
June 23, 2005
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
US Department of Veterans Affairs
search

1. Study Identification

Unique Protocol Identification Number
NCT00000312
Brief Title
Alterations in Serotonergic Functions in Cocaine Addicts - 1
Official Title
Alterations in Serotonergic Functions in Cocaine Addicts
Study Type
Interventional

2. Study Status

Record Verification Date
December 2002
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
US Department of Veterans Affairs

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to evaluate alterations in the serotonergic system in cocaine addicts and attempt to dissociate changes secondary to cocaine use from those associated with premorbid characteristics.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Enrollment
0 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
M-CPP
Primary Outcome Measure Information:
Title
Side effects
Title
Neuroendocrine changes
Title
Psychological changes
Title
Craving

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laure Buydens-Branchey, M.D.
Organizational Affiliation
VA Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Medical Center
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11209
Country
United States

12. IPD Sharing Statement

Citations:
Citation
Biological Psychiatry (in press) The. AM. Int. on Addictions (in press)
Results Reference
background

Learn more about this trial

Alterations in Serotonergic Functions in Cocaine Addicts - 1

We'll reach out to this number within 24 hrs